Literature DB >> 19496924

The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome.

C Frére, T Cuisset, B Gaborit, M-C Alessi, J-S Hulot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19496924     DOI： 10.1111/j.1538-7836.2009.03500.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  33 in total

1.  Early dual antiplatelet therapy in stroke: should we take the CHANCE?

Authors:  Ethan S Brandler; Mohit Sharma
Journal:  Ann Transl Med       Date:  2015-08

Review 2.  Personalized medicine: is it a pharmacogenetic mirage?

Authors:  Rashmi R Shah; Devron R Shah
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

Review 3.  Genetics of platelet inhibitor treatment.

Authors:  Dietmar Trenk; Willibald Hochholzer
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 4.  The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19.

Authors:  Yao Yang; Joshua P Lewis; Jean-Sébastien Hulot; Stuart A Scott
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-07-14       Impact factor: 4.481

5.  Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.

Authors:  S A Scott; S Martis; I Peter; Y Kasai; R Kornreich; R J Desnick
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

Review 6.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

Review 7.  Role of antiplatelet therapy in secondary prevention of acute coronary syndrome.

Authors:  Mathieu Pankert; Jacques Quilici; Thomas Cuisset
Journal:  J Cardiovasc Transl Res       Date:  2011-11-06       Impact factor: 4.132

Review 8.  Recent advances in the pharmacogenetics of clopidogrel.

Authors:  Thomas Cuisset; Pierre-Emmanuel Morange; Marie-Christine Alessi
Journal:  Hum Genet       Date:  2011-12-30       Impact factor: 4.132

9.  Genetic testing for CYP450 polymorphisms to predict response to clopidogrel: current evidence and test availability. Application: pharmacogenomics.

Authors:  Renée M Ned Mmsc Phd
Journal:  PLoS Curr       Date:  2010-09-20

Review 10.  Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Authors:  Mohamed H A Shahin; Julie A Johnson
Journal:  Curr Opin Cardiol       Date:  2013-05       Impact factor: 2.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.